Cell segmentation, protein structure annotation, genomic data labeling, and drug discovery data preparation for biotech and pharmaceutical AI models.
Cell types, subcellular structures, phenotype categories, and morphological descriptors defined with client scientists. Visual reference atlas built from published literature and client-provided exemplars.
Channel separation, background subtraction, and contrast normalization applied. Z-stack images processed for maximum intensity projection or 3D annotation depending on project requirements.
Per-cell instance segmentation with nucleus/cytoplasm/membrane delineation. Multi-class labeling for cell type, division stage, viability status, and phenotypic markers.
Drug response phenotypes labeled across dose-response plates: cell morphology changes, apoptosis indicators, migration patterns, and proliferation metrics for compound efficacy scoring.
L2 reviewers with PhD-level biology backgrounds validate cell identifications, phenotype classifications, and segmentation boundaries. Dice ≥ 0.88 enforced for segmentation tasks.
Annotations delivered with full traceability for GLP/GMP compliance: reviewer credentials, protocol version, standard operating procedures, and electronic signatures per 21 CFR Part 11.
Generic annotation vendors can label data. Domain experts label it correctly. Here's why the difference matters in your industry.
Distinguishing a mitotic cell from an apoptotic cell requires understanding of biological processes — not just shape recognition. Our annotators hold biology degrees and are trained on client-specific phenotype definitions with published literature references.
Pharmaceutical AI models used in drug discovery must comply with GLP/GMP regulations. Our annotation pipeline produces 21 CFR Part 11 compliant deliverables with electronic signatures, audit trails, and protocol version control.
Biotech datasets are often small (thousands, not millions of images) due to experimental costs. When your entire training set is 5,000 images, a 2% error rate means 100 wrong labels that can significantly skew model behavior. Our 98.5% accuracy is critical.
See how our domain-specific capabilities compare to generic annotation services.
| Capability | UTL Data Engine | Typical Vendor |
|---|---|---|
| PhD-level biology reviewers for QA | Cell bio, molecular bio, pathology | General annotators |
| 3D volumetric (confocal Z-stack) annotation | Slice-by-slice + 3D | 2D only |
| High-content screening phenotype labeling | Dose-response aware | Basic classification |
| GxP compliance (GLP/GMP/21 CFR Part 11) | Full documentation | Not available |
| Dice ≥ 0.88 for cell segmentation | Enforced | Not measured |
| Multi-channel fluorescence annotation | Per-channel + merged | Single channel |
"Finding annotators who understand cell biology is incredibly hard. UTL's biotech-trained team delivered high-accuracy segmentation masks that directly improved our drug screening model."
Let's discuss your specific data challenges and build a tailored annotation pipeline.
